Inozyme Pharma • INZY
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Douglas A. Treco, PhD$267.5M
Market Cap • 25/04/20242015
(há 9 anos)
2020
(4 years ago)
NASDAQ
Listagem
Boston
Sede • Massachusetts56
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
INZYSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.